FDA 483 - Lusys Laboratories, Inc. - September 24, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Lusys Laboratories, Inc. in San Diego, CA, received a Form 483 with four observations during an FDA inspection. The firm was cited for failing to validate manufacturing processes for COVID-19 test strips and for not establishing adequate procedures to control environmental conditions for finished products. Additionally, the inspection revealed deficiencies in the firm's corrective and preventive action (CAPA) system and a failure to maintain complete distribution records for medical devices.
ID · e6a45b80-b07f-4380-b023-468bd7142dd6